Back to Trades
Grossman William
Interim Chief Medical OfficerDirectorCIK 0001730229
Profile
- Filings
- 5
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
Grossman William, Interim Chief Medical Officer, Director, accounts for 5 disclosed filings worth $3.9M, spread across 2 companies, active 2025–2026. The record is heavily weighted toward buying, with $10.1K in purchases against $0 in sales. The largest single open-market purchase on record is $10.1K in enGene Therapeutics Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Sep 24 | ENGN enGene Therapeutics Inc. | Grossman William | Interim Chief Medical Officer, Director | Buy | $10.1K |
| Jun 17 | ENGN enGene Therapeutics Inc. | Grossman William | Insider | Award | $404.3K |
| Apr 23 | DAWN Day One Biopharmaceuticals, Inc. | Grossman William | Insider | Disposed | $1.0M |
| Nov 7 | DAWN Day One Biopharmaceuticals, Inc. | Grossman William | Insider | Award | $2.3M |
| Jul 10 | ENGN enGene Holdings Inc. | Grossman William | Insider | Award | $172.3K |
5 filings